Tag Archive for: Director

Rachael Fleurence, PhD, Joins MDIC as Executive Director, Coordinating Center

Life Science Partner recruited Rachael Fleurence, PhD, to serve as the MDIC’s Executive Director, Coordinating Center in partnership with the National Evaluation System for Health Technology (NEST).

MDIC is the first-ever public-private partnership (PPP) created with the sole objective of advancing medical device regulatory science. MDIC is a nonprofit 501(c)3 organization that operates in partnership with the FDA to improve the medical technology environment. The U.S. Food and Drug Administration (FDA) has awarded the MDIC $3 million in seed funding to establish the Coordinating Center for the Medical Device National Evaluation System for health Technology (NEST).

While at PCORI, Fleurence lead the launch of PCORnet, a national patient centered research network consisting of 130 institutions and patient groups nationwide. She also directed the Clinical Research Methods program in areas including comparative effectiveness research, methods for patient engagement and research prioritization and analytical methodologies.

“The initial phase of the NEST project will include demonstration projects piloting methods for tracking medical device data and patient-reported outcomes through the use of real-world evidence., Fleurence has the unique capability to lead the vision and execution of the MDIC’s Coordinating Center in partnership with NEST,” states Tom Callaway, MD, Founder of Life Science Partner.

Rachael Fleurence earned her Bachelor of Arts Degree in Social and Political Science from University of Cambridge, UK, and her MA in business management from ESSEC- Paris. She completed her Master of Science and PhD in health economics from the University of York. She also completed her AMIA 10X10 Bioinformatics Certificate from the Oregon Health and Sciences University.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Learn More About Chief Executive Functions
/0 Comments/by

Tony Brennan Joins UL as Director, North American Sales

Former Director, Business Development at Erdman

Tony Brennan has joined Underwriters Laboratories as Director, North American Sales for the company’s Health Sciences business unit reporting to Upayan SenGupta, Vice President, General Manager, Health Sciences—SenGupta was recruited to UL by Life Science Partner in 2015. Brennan previously served as Director, Business Development for Erdman, a consulting firm dedicated to providing integrated solutions for healthcare clients.

Brennan’s career has been focused on building and leading strategic healthcare sales teams and cultivating key relationships with Group Purchasing Organizations and Integrated Delivery Networks. He has previously held sales leadership roles at HeartSine Technologies, Angelica, Cardionow, Cordis and GE Healthcare.

In his role at UL, Brennan will oversee the sales and new business development for the company’s rapidly growing Health Sciences Division. Brennan will be lead the transformation of the business from selling traditional compliance and audit services to becoming a proactive partner in the registration and product development teams for UL’s clients.

Brennan earned his Bachelor of Science in Biology and Chemistry from Bowling Green State University.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Learn More About Chief Executive Functions
/0 Comments/by

Chris Stein, MD, PhD, Joins Allergan As Director, Medical Safety Physician

Former Global Pharmacovigilance and Clinical Safety Physician Otsuka Pharmaceuticals

Chris Stein, MD, PhD, was recruited by Life Science Partner to serve as Director, Medical Safety Physician for Allergan where he will oversee Pharmacovigilance for Allergan’s CNS drug portfolio.

In his previous role at Otsuka, Stein partnered with safety physicians at Bristol Myers Squibb to co-market the block buster drug, Abilify, and formulate a regulatory compliance strategy and risk management plan while providing signal evaluation and drug safety reporting.

“Intelligent, articulate and passionate about pharmacovigilance, Stein will be able to hit the ground running in his CNS role for Allergan’s pharmacovigilance team,” states Tom Callaway, MD, Founder and President of Life Science Partner. “He brings exceptional analytical and writing skills to be a great addition to the team.”

Chris Stein earned his Bachelor of Science Degree in Biology and Computer Science in 1984 from the Southwest Missouri State University. He completed his MD and PhD from the St. Louis University School of Medicine and his MPH from the University of Kentucky College of Public Health.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Judi Jaeger Joins Beckman Coulter as Director, Global Clinical Affairs

Former Vice President, Clinical Affairs at Elixir Medical

Life Science Partner has recruited Judi Jaeger to become Director, Global Clinical Affairs at Beckman Coulter reporting to Kim Oleson, Vice President of Clinical Affairs for Danaher’s Life Sciences and Diagnostics Platform.

“With first-hand leadership experience in the clinical development of two world-leading Class III devices and the ability to build and lead global teams, Jaeger’s scientific background in complex technologies and the regulatory intricacies will set her up to thrive and deliver at Beckman Coulter,” states Tom Callaway, MD, President and Founder of Life Science Partner.

During her clinical career, Jaeger was a critical part of Medtronic’s clinical team’s success in getting the Resolute product approved globally as well serving as key role for the worldwide approval of Johnson & Johnson/Cordis’ Cypher coated stent.

Jaeger earned her Bachelor of Arts Degree as a Psychology Major from Rutgers University in 1986.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Courtney Barton Joins Allergan – Director, Corporate Compliance

Former Director, Corporate Compliance & Global Data Privacy at Bausch & Lomb

Life Science Partner recruited Courtney Barton, an experienced global compliance executive, to become Director, Corporate Compliance for Allergan Medical.

In her new role, Barton will be responsible for leading compliance with CIA directives and developing Allergan’s compliance policies for the $1.4B medical device businesses.  Barton will report to the Vice President and Deputy Director Wes Porter.  Porter was recruited by Life Science Partner to Allergan in 2012.

Prior to her new position at Allergan, Barton spent much of her career at Bausch & Lomb where she played a key role in building and maintaining the Company’s current Compliance Program.

Barton earned Bachelor of Arts in International Relations and Political Science from Syracuse University.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Dan Merz Joins St. Jude Medical as Director, Clinical Affairs

ATLANTA, Georgia – March 14 2013

Life Science Partner announces the recruitment of Dan Merz to become Director, Clinical Affairs for St. Jude Medical. Merz is an innovative engineer who has created teams and processes to improve the speed of clinical development and product approval in the US and Japan.

Merz’s leadership capabilities will serve him well in his new role as Director, Clinical Affairs at St. Jude Medical, where he will have the responsibility for clinical trial monitoring, budget and clinical trial agreement process, as well as the responsibility for directly leading the teams accountable for the clinical program activities for the Portico TVH valve studies.

In his most recent role, Merz served as Director, Clinical and Regulatory Affairs for American Medical Systems (AMS) where he led the organizational redesign of AMS clinical research executive teams to align with Endo Pharmaceuticals. Since the realignment of the clinical organizations, Merz launched 292 patient randomized trials in Europe with 30 sites involving 11 nations.

“Merz is an articulate leader who has motivated teams to overcome regulatory hurdles and as to provide new tools for physicians to treat their patients,” noted Tom Callaway, MD, founder of Life Science Partner. “He has successfully built and led clinical organizations to move an innovative technology to the market.”

Merz earned his Bachelor of Science Degree in Biomedical Engineering at Northwestern University.

Recruiting Transformational Leaders

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Tina Webb Joins Allergan as Director, Business Compliance, Pharmaceuticals

Life Science Partner recruits former Associate Director, US Pharmaceuticals Compliance and Ethics for Bristol-Myers Squibb

Allergan, Inc. is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices in the areas of eye care, neurosciences, medical dermatology and urologics. The company is best known for its Botox franchise.

Tina Webb, an experienced pharmaceutical compliance executive, has joined Allergan as the Director of Business Compliance, Pharmaceuticals. 

In this role, she will be responsible for providing advice and leading efforts regarding Allergan’s compliance policies and procedures for the pharmaceutical business within the United States.  She will work with the sales force to build communication strategies and messages that are effective but consistent with the product’s approved uses – and create solutions that enhance physician customer relations with the CIA guidelines.

In her previous role at Bristol-Myers Squibb, Webb was responsible for developing, overseeing and maintaining the Company’s US Compliance and Ethics program.  She successfully brought automation and systemization of the compliance program that allowed the sales and marketing organization to function more effectively while in compliance.

“Tina has an analytical and legal approach to compliance combined with a sales-oriented personality,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “Her broad experience in creating and implementing compliance programs for US Sales and Marketing organizations will be a great asset for the Allergan Compliance team.”

Webb earned her degree from Rutgers University in New Brunswick, NJ.

About Life Science Partner

Life Science Partner’s high-quality executive, research and professional placement services target the very specific needs of life sciences and healthcare organizations. We identify and recruit the brightest talent in the biotechnology, pharmaceutical, medical device, academic and healthcare services fields.  Our combined scientific backgrounds and senior management experience give us the scientific literacy and business knowledge to help us better understand challenges, refine requirements and work more effectively with our life science clients.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Mark Adler Joins Medtronic Diabetes as Director, Research and Development, Sensors Engineering

Life Science Partner recruits former Vice President of Manufacturing and Manufacturing Engineering at GluMetrics

Life Science Partner announces the recruitment of Mark Adler to become Director, Research and Development, Sensors Engineering for Medtronic Diabetes.

Medtronic Diabetes is the world leader in insulin pump therapy and continuous glucose monitoring.

In his most recent role at GluMetrics, Adler was responsible for building the intensive care unit glucose sensor product portfolio for the emerging medical device company.  He has a broad background in breakthrough device development in many different platforms – including coating vascular stents at Devax and creating a new sensor platform at DexCom as Senior Director of Manufacturing Operations and Engineering.  This new role is somewhat of a homecoming, as he was previously the Director of Advanced Engineering at Medtronic AVE.

Mark Adler

In his new role at Medtronic Diabetes, Adler will be responsible for determining and executing the overall strategic technology plan for the sensors development organization, as they help build the next-generation sensors and cutting edge continuous glucose monitoring solutions.

“Adler is a passionate, highly motivated engineering executive with an impressive background in sensor development for the diabetes market” noted Tom Callaway, MD, founder and president of Life Science Partner.  “He has broad management experience across all functions of a medical device organization and will bring leadership and quality execution to Medtronic Diabetes’ portfolio of continuous glucose monitoring solutions.”

Adler received his Bachelor of Technology Degree in Mechanical Engineering from the Rochester Institute of Technology and his Masters in Business Administration from Argosy University, Seattle.

Learn More About the Medical Device Industry
/0 Comments/by

Shubhayu Basu to join the Global Cardiovascular Innovation Center as Director of Product Development

Life Science Partner recruits Innovative R&D Scientist.

Life Science Partner announces the recruitment of Shubhayu Basu, PhD, formerly Group Lead for New Business Ventures at Abbott Vascular, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio.

The organization was launched with a $60 million grant for the State of Ohio to develop and commercialize new cardiovascular products.  GCIC will focus on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.

In Basu’s former role at Abbott Vascular (formerly Guidant), he was responsible for creating and implementing processes for identifying emerging technologies and various disease spaces and opportunities against the company portfolio and growth landscape.   Previously, he served as Group Lead, Research and Development, Cardiac Therapies for the company.

Prior to joining Guidant/Abbott, Basu was a Biodesign Innovation Fellow at Stanford University’s Biodesign Program in Palo Alto, CA.

“Basu will join another LSP recruit – Gene Jung – who shares his passion about new technologies and their application in patient care,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “His ability to work with complex technologies to identify commercial opportunities and to oversee their development is a perfect fit for the GCIC team.”

Basu earned both his Bachelor and Masters Degree of Technology in Biochemical Engineering and Biotechnology at the Institute of Technology in New Delhi, India.  He received his PhD in Chemical Engineering at the Ohio State University in Columbus.

/0 Comments/by

Mark Low joins the Global Cardiovascular Innovation Center as Managing Director

Life Science Partner recruits Senior Leader from the Cardiovascular Medical Device Industry.

Life Science Partner announces the recruitment of Mark Low, a senior cardiovascular medical device executive, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio. 

Headquartered on the campus of The Cleveland Clinic, GCIC was launched with a $60 million grant for the State of Ohio through its Wright Center of Innovation program to develop and commercialize new cardiovascular products.  Working with the GCIC’s Board of Directors and Commercialization Advisory Board, Low will build a team to utilize the considerable clinical, research and commercialization capabilities of the GCIC member organizations in northeast Ohio.

GCIC will be focused on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.

Low has spent most of his career developing new cardiovascular technologies in both small, venture-backed companies and large medical device companies.   He has most recently provided market analysis, strategy and business development services for cardiovascular applications and technologies as an independent consultant.  Previously, Low was Vice President of Business and Market Development for Sonus Pharmaceuticals, Inc., a drug delivery and specialty pharmaceutical company in Bothell, Washington.  Earlier he led the market development of intra-vascular ultrasound (IVUS) at Hewlett Packard.

“Low is a well-networked and experienced marketing and commercialization executive in the field of cardiovascular technologies,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “Working with GCIC and its affiliate institutions, Low will connect technology leaders at Cleveland Clinic and Case Western with corporate leaders and venture funding sources.”

Low earned a Bachelor of Arts in Natural Science from Johns Hopkins University, a Master of Science in Physiology from the Medical College of Wisconsin, and a Master of Science in Technical Communication from Rensselaer Polytechnic Institute.

/0 Comments/by